BioCentury | Sep 22, 2017
Politics, Policy & Law

Conferred immunity in IPR

...of America (PhRMA), Washington, D.C. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA), Petah Tikva, Israel University of Georgia Research Foundation...
BioCentury | Jan 16, 2012
Strategy

Going viral

...zoster virus (VZV) infection. Next, Inhibitex exclusively licensed a preclinical HIV integrase inhibitor from the University of Georgia Research Foundation...
...NYSE:MRK), Whitehouse Station, N.J. Pharmasset Inc. (NASDAQ:VRUS), Princeton, N.J. University of Cardiff , Cardiff, U.K. University of Georgia Research Foundation...
BioCentury | Oct 24, 2011
Company News

VaxyGen Holdings LLC, University of Georgia Research Foundation deal

...foundation is eligible for royalties. Terms were not disclosed. VaxyGen Holdings LLC , location undisclosed University of Georgia Research Foundation...
BioCentury | May 2, 2011
Company News

Bukwang, University of Georgia Research Foundation, Yale University deal

...antiviral agent. Further terms were not disclosed. Bukwang Pharmaceutical Co. Ltd. , Seoul, South Korea University of Georgia Research Foundation...
BioCentury | Aug 25, 2008
Company News

ArunA Biomedical Inc., University of Georgia Research Foundation deal

...kit in early 1Q09. Financial terms were not disclosed. ArunA Biomedical Inc. , Athens, Ga. University of Georgia Research Foundation...
BioCentury | Sep 17, 2007
Company News

Inhibitex, University of Georgia Research Foundation deal

...three years of R&D funding, and potential milestones and royalties. Inhibitex Inc. (INHX), Atlanta, Ga. University of Georgia Research Foundation...
BioCentury | Jan 29, 2007
Company News

Aruna Biomedical Inc., University of Georgia Research Foundation deal

...undisclosed third-party distribution partner. Financial terms were not disclosed. Aruna Biomedical Inc. , Athens, Ga. University of Georgia Research Foundation...
BioCentury | Jan 1, 2007
Company News

Euroscreen, PerkinElmer deal

...Euroscreen Products' exclusive worldwide license to AequoScreen aequorin-based luminescent cellular assay technology, granted by the University of Georgia Research Foundation...
BioCentury | Aug 15, 2005
Company News

RFS infectious, cancer, dermatology news

...Sciences Inc. (GILD, Foster City, Calif.) returned rights to the compound to Emory and the University of Georgia Research Foundation...
BioCentury | Aug 15, 2005
Finance

Ebb & Flow

...is in Phase II testing to treat HIV and HBV, from Emory University and the University of Georgia Research Foundation...
Items per page:
1 - 10 of 15
BioCentury | Sep 22, 2017
Politics, Policy & Law

Conferred immunity in IPR

...of America (PhRMA), Washington, D.C. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA), Petah Tikva, Israel University of Georgia Research Foundation...
BioCentury | Jan 16, 2012
Strategy

Going viral

...zoster virus (VZV) infection. Next, Inhibitex exclusively licensed a preclinical HIV integrase inhibitor from the University of Georgia Research Foundation...
...NYSE:MRK), Whitehouse Station, N.J. Pharmasset Inc. (NASDAQ:VRUS), Princeton, N.J. University of Cardiff , Cardiff, U.K. University of Georgia Research Foundation...
BioCentury | Oct 24, 2011
Company News

VaxyGen Holdings LLC, University of Georgia Research Foundation deal

...foundation is eligible for royalties. Terms were not disclosed. VaxyGen Holdings LLC , location undisclosed University of Georgia Research Foundation...
BioCentury | May 2, 2011
Company News

Bukwang, University of Georgia Research Foundation, Yale University deal

...antiviral agent. Further terms were not disclosed. Bukwang Pharmaceutical Co. Ltd. , Seoul, South Korea University of Georgia Research Foundation...
BioCentury | Aug 25, 2008
Company News

ArunA Biomedical Inc., University of Georgia Research Foundation deal

...kit in early 1Q09. Financial terms were not disclosed. ArunA Biomedical Inc. , Athens, Ga. University of Georgia Research Foundation...
BioCentury | Sep 17, 2007
Company News

Inhibitex, University of Georgia Research Foundation deal

...three years of R&D funding, and potential milestones and royalties. Inhibitex Inc. (INHX), Atlanta, Ga. University of Georgia Research Foundation...
BioCentury | Jan 29, 2007
Company News

Aruna Biomedical Inc., University of Georgia Research Foundation deal

...undisclosed third-party distribution partner. Financial terms were not disclosed. Aruna Biomedical Inc. , Athens, Ga. University of Georgia Research Foundation...
BioCentury | Jan 1, 2007
Company News

Euroscreen, PerkinElmer deal

...Euroscreen Products' exclusive worldwide license to AequoScreen aequorin-based luminescent cellular assay technology, granted by the University of Georgia Research Foundation...
BioCentury | Aug 15, 2005
Company News

RFS infectious, cancer, dermatology news

...Sciences Inc. (GILD, Foster City, Calif.) returned rights to the compound to Emory and the University of Georgia Research Foundation...
BioCentury | Aug 15, 2005
Finance

Ebb & Flow

...is in Phase II testing to treat HIV and HBV, from Emory University and the University of Georgia Research Foundation...
Items per page:
1 - 10 of 15